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Objective. To test the hypothesis that maternal obesity is an independent risk factor for rectovaginal group B streptococcus (GBS)
colonization at term. Study Design. Retrospective cohort study of consecutive women with singleton term pregnancies admitted
in labor at Barnes-Jewish Hospital (2004–2008). Maternal BMI ≥ 30Kg/m2 (obese) or <30Kg/m2 (nonobese) defined the two
comparison groups. The outcome of interest was GBS colonization from a positive culture. Baseline characteristics were compared
using Student’s t-test and Chi-squared or Fisher’s exact test. The association between obesity and GBS colonization was assessed
using univariable and multivariable analyses. Results. Of the 10,564 women eligible, 7,711 met inclusion criteria. The prevalence of
GBS colonization in the entire cohort was relatively high (25.8%). Obese gravidas were significantly more likely to be colonized
by GBS when compared with nonobese gravidas (28.4% versus 22.2%, 𝑃 < 0.001). Obese gravidas were still 35% more likely than
nonobese women to test positive for GBS after adjusting for race, parity, smoking, and diabetes (adjusted OR 1.35 [95% CI 1.21–
1.50]). Conclusion. Maternal obesity is a significant risk factor for GBS colonization at term. Further research is needed to evaluate
the impact of this finding on risk-based management strategies.
1. Introduction
Group B streptococcus (GBS) was first recognized as a viru-
lent pathogen responsible for most cases of neonatal sepsis in
1964 [1]. Since then, GBS has been associated with neonatal
meningitis, pneumonia, septic abortions, and chorioam-
nionitis. It has also been implicated in puerperal sepsis,
endometritis, and urinary tract infections [2, 3]. Bergqvist et
al. showed that the vagina was the most likely source of GBS
to the neonate as the antibiotic sensitivities of the neonatal
organisms were similar to maternal vaginal cultures [2].
Intrapartum chemoprophylaxis has been shown to
decrease early-onset neonatal GBS disease [4, 5]. In 1996
the American College of Obstetricians and Gynecologists,
the Centers for Disease Control and Prevention (CDC),
and the American Academy of Pediatrics (AAP) made
recommendations for intrapartum prophylaxis to prevent
perinatal GBS disease based on risk factors [6–8]. The
CDC published revised guidelines in 2002 recommending
universal culture-based screening at 35–37 weeks with
intrapartum chemoprophylaxis for those who test positive.
Risk-based treatment was recommended if GBS colonization
status is unknown during labor. The risk factors considered
included a prior affected infant, prematurity, prolonged
rupture of membranes, and history of GBS bacteriuria
during the current pregnancy, all of which are associated
with increased risk of neonatal GBS disease.
Othermaternal factors have been suggested as risk factors
for GBS colonization. A number of studies have linked
obesity to GBS colonization in both pregnant and nonpreg-
nant women [9–11]. Further, obesity has been linked to an
increased risk of early-onset neonatal GBS disease [12]. Most
of the prior studies were based on population-based data
with intrinsic limitations and somedid not adequately control
for potential confounders [13]. With the increasing rates of
obesity, establishing an association with GBS colonization
may inform risk-based intrapartum prophylaxis for women
with unknown GBS status in labor.
The objective of this study was to investigate the asso-
ciation between obesity and GBS colonization in a term
Hindawi Publishing Corporation
Infectious Diseases in Obstetrics and Gynecology
Volume 2015, Article ID 586767, 5 pages
http://dx.doi.org/10.1155/2015/586767
2 Infectious Diseases in Obstetrics and Gynecology
cohort. We tested the hypothesis that maternal obesity is an
independent risk factor for rectovaginal GBS colonization at
term.
2. Methods
This was a retrospective cohort study of all consecutive
women with singleton term pregnancies admitted in labor at
WashingtonUniversity in St. LouisMedical Center from2004
to 2008. We obtained informed consent and the study was
approved by the Washington University School of Medicine
Human Research Protection Office.
Women with documented GBS culture results and body
mass index (BMI) information were eligible. We excluded
womenwithoutGBS and BMI information andwomen deliv-
ering preterm (<37 weeks). Extensive data were extracted
from the medical record including maternal sociodemo-
graphic factors, obstetric and gynecologic history, medical
and surgical history, antenatal history, and obstetric out-
comes. Maternal BMI was calculated from the patients’
weight and height on admission. Obesity was defined using
WHO criteria as BMI ≥ 30Kg/m2. Term gestations were
defined as gestational age of at least 37 0/7 weeks. Pregnancies
were dated by awoman’s lastmenstrual period and confirmed
with first or second trimester ultrasonography using standard
criteria. The outcome of interest was GBS colonization,
defined as positive culture from a rectovaginal swab. Those
individuals were treated as per CDC guidelines.
Maternal BMI ≥ 30Kg/m2 (obese) or <30Kg/m2
(nonobese) defined the comparison groups. Baseline
characteristics were compared using univariable analysis.
Continuous variables were compared using Student’s 𝑡-test
and categorical variables were analyzed using the Chi-
square or Fisher’s exact test as appropriate. Normality of
distribution of the continuous variables was verified using
the Kolmogorov-Smirnov test. The association between
obesity and GBS colonization was assessed using adjusted
and unadjusted odds ratios with 95% confidence intervals.
Adjusted odds ratios were obtained using multivariable
logistic regression to control for confounders. Candidate
variables for the logistic regression models were selected on
the basis of biologic plausibility, risk factors that have been
identified in the literature, and results of our univariable
analysis. Backwards elimination was used to reduce the
number of variables in each model. Differences between
hierarchical explanatory models were assessed using the
likelihood ratio test or Wald test. Only factors contributing
significantly to the explanatory model were included in
the final model. Model fit was assessed with the Hosmer-
Lemeshow goodness-of-fit test [14].
We included all consecutive subjects meeting inclusion
criteria; no a priori sample size estimation was performed.
Statistical tests were all 2-tailed and 𝑃 < 0.05 was considered
significant. All statistical analyses were completed using
















Figure 1: Flowchart of study subjects.
Table 1: Characteristics of study subjects (𝑁 = 7,711).
Variable Obese(𝑛 = 4492)
Nonobese
(𝑛 = 3219) 𝑃
Maternal age, mean (sd) 25.4 (5.9) 24.2 (6.2) <0.001
Gestational age in weeks,
mean (sd) 39.0 (1.2) 38.9 (1.2) <0.001
Race, 𝑛 (%)
Black 3,380 (75.2) 2,135 (66.3)
<0.001
Caucasian 801 (17.8) 710 (22.1)
Primiparous, 𝑛 (%) 1,517 (33.8) 1,383 (43.0) <0.001
Vaginal delivery, 𝑛 (%) 2,875 (64.0) 2505 (77.8) <0.001
Smoking, 𝑛 (%) 794 (17.7) 594 (18.5) 0.381
Alcohol, 𝑛 (%) 51 (1.1) 52 (1.6) 0.070
Illicit drug use, 𝑛 (%) 414 (9.2) 356 (11.1) 0.008
Diabetes mellitus, 𝑛 (%) 134 (3.0) 15 (0.47) <0.001
Chronic hypertension, 𝑛
(%) 212 (4.7) 37 (1.2) <0.001
sd: standard deviation.
3. Results
Of the 10,564 women admitted in labor at term during the
study period, 7,711met inclusion criteria (Figure 1).More than
half of the cohort was obese (𝑛 = 4, 492, 58.3%). Majority
of the women were African American (𝑛 = 5, 515, 71.5%)
with amean gestation age of 38.9 weeks. Obese and nonobese
women were different in several baseline characteristics.
Obese women were more likely to be older, Africa American,
and having diabetes (Table 1).
The prevalence of GBS colonization in the entire cohort
was relatively high (25.8%). Obese women were significantly
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𝑛 (%) Unadjusted odds ratio (95% CI)
∗Adjusted odds ratio (95% CI) 𝑃 trend
<30 (𝑛 = 3,219) 713 (22.2) Reference Reference
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Figure 2: Risk of GBS colonization with increasing obesity cate-
gories.
more likely than nonobese women to be colonized by GBS
(28.4% versus 22.2%, crude OR 1.39 (95% CI 1.25, 1.55), 𝑃 <
0.001). After adjusting for race, parity, and diabetes, obese
women were still 35% more likely to be colonized with GBS
(adjusted OR 1.35 (95% CI 1.21–1.50)).
To determine if there is a dose-response relationship
between increasing BMI category and GBS colonization, we
calculated the risk of GBS colonization for BMI < 30Kg/m2,
30–39.9, and ≥40Kg/m2. GBS colonization increased in a
dose-response fashion with increasing BMI: 22.2%, 27.3%,
and 31.7%, respectively (Figure 2). The trend persisted in
multivariable analysis adjusting for confounders (Table 2).
4. Discussion
Widespread efforts, using a combination of screening and
risk factor-based strategies, have resulted in a significant
reduction in the incidence of early-onset neonatal sepsis
due to GBS [15, 16]. Yet, GBS remains the leading cause of
infectious mortality and morbidity in newborns [16]. While
obesity has not been considered one of the risk factors for
which intrapartum prophylaxis should be offered to women
with unknown GBS status, our results show that obesity is
associatedwith a 35%higher risk of GBS colonization at term.
The finding of an association between obesity and GBS
colonization is consistent with prior studies [9–11]. Using
population-based data, Stapleton et al. found a 20% increased
risk of GBS colonization with obesity and 45% increase with
severe obesity [11].The 25.8% overall rate of GBS colonization
in our cohort is relatively high but still falls within the 10–
30% rates reported in the literature [17–20]. This higher
rate may be attributable to a number of factors. First, our
cohort is predominantly African American, a known risk
factor for GBS colonization. Second, over 50% of our cohort
was obese. Given the observed association between obesity
and GBS colonization, this may explain the overall higher
colonization rate. Third, prior studies report an increasing
trend of GBS colonization over time. Stapleton et al. reported
a progressive increase in GBS prevalence from 1997 to
2002, which was attributed to increased screening [11]. This
may further explain the relatively higher rate noted in our
contemporary cohort. Finally, our study differs from prior
studies by including only women at term.
Thebiologicalmechanism for increasedGBS colonization
in obese women is unclear. However, it may be related to
changes in the gastrointestinal microbial ecology with obe-
sity. Animal and human studies demonstrate a shift towards
increased Firmicutes (the phylum towhichGBS belongs) and
decreased Bacteroides with obesity [21]. These shifts reflect
increased energy-reabsorbing potential of different ratios of
Firmicutes andBacteroides, especially in the digestion of fatty
acids and dietary polysaccharides [22]. Further, a recent study
showed that pregnancy itself is associated with changes in the
gut microbiome similar to that seen in obesity [23].
Our study offers several strengths. This is a large analysis
dedicated to evaluating the association between obesity and
GBS colonization at term. The comprehensive delivery data
compiled by trained research nurses enabled us to perform
detailed analysis controlling for confounders. Further, by
including only women at term, we focused on the subset
of women in whom additional risk factors would influence
clinical management if GBS status is unknown.
There are limitations that should be considered when
interpreting our data. The retrospective nature of our study
makes it vulnerable to selection bias, confounders, and
inaccuracies in data collection. We included all consecu-
tive patients meeting inclusion criteria, reducing the risk
of selection bias. In addition, our database has been well
validated by ongoing quality control, increasing confidence
in our findings. While we controlled for confounders, there
is the potential for residual confounding by variables we
did take into account. Finally, our cohort is predominantly
African American, raising the question of generalizability of
our results. However, the persistent association after we con-
trolled for confounders including race and the consistency of
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our results with other studies conducted among subjects of
different demographics lend credence to the generalizability
of our findings. Further studies in different populations will
help further validate our findings.
One prior study found a higher risk of early-onset GBS
sepsis in the neonates of obese women [12]. The results of
that study coupled with our findings suggest that obesity
may be both an important risk factor for GBS colonization
and neonatal GBS disease. If these findings are confirmed
by other studies, obesity may be considered in risk-based
management strategies in women at term. Furthermore, a
recent study reported a false negative antepartum culture rate
of 9.8% [24], highlighting the potential role of risk factor
based management strategies.
5. Conclusion
In conclusion, this large cohort study showed a significantly
increased risk of GBS colonization in obese women at term.
If confirmed by other studies, this finding, together with the
reported higher risk of early-onset GBS in neonates of obese
women, suggests that maternal obesity is a factor that needs
to be considered in strategies for reducing GBS disease in
neonates.
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